news 2022

« BACK

Pharmacology



Results 1 - 9 of 9.


Health - Pharmacology - 20.01.2022
More than a third of care home residents caught Covid-19 in early waves of pandemic
More than a third of care home residents caught Covid-19 in early waves of pandemic
More than a third of care home residents and a quarter of care home staff in England showed evidence of infection with SARS-CoV-2 during the first two waves of the pandemic, according to a new study led by UCL researchers. The study, published in The Lancet Healthy Longevity , looked at blood samples from nearly 5,000 residents (with a median age of 87) and staff (with a median age of 48) at 201 care homes across England between June 2020 and May 2021.

Pharmacology - Health - 19.01.2022
New blood cancer gene defect can be treated with existing drugs
Share this page Share on Twitter Share on facebook Share on linkedin Share on email A defective gene normally found in blood cancers could be treated with drugs already available for cancers with similar gene defects, scientists at the University of Birmingham and Queen's University Belfast have revealed.

Health - Pharmacology - 18.01.2022
'Off target' effects of drugs used for autoimmune disorders needs better treatment strategy
’Off target’ effects of drugs used for autoimmune disorders needs better treatment strategy
New therapies for autoimmune rheumatic diseases (AIRDs) that are designed to better regulate lipid (fat) metabolism, could significantly reduce the harmful side-effects caused by conventional treatments, finds a new large-scale review led by UCL researchers. AIRDs affect millions globally and include rheumatoid arthritis, lupus and Sjögren's syndrome - all with high rates of morbidity.

Pharmacology - Life Sciences - 13.01.2022
Promising novel treatment for Dry Eye Disease revealed by new research
Promising novel treatment for Dry Eye Disease revealed by new research
The University of Manchester, Seoul National University College of Medicine and Link Biologics Limited today announced that promising preclinical data on the treatment of Dry Eye Disease using a novel protein biological drug, Link_TSG6, have been published in the peer-reviewed journal, Ocular Surface .

Physics - Pharmacology - 13.01.2022
Keeping up with the first law of robotics: A new photonic effect for accelerated drug discovery
Keeping up with the first law of robotics: A new photonic effect for accelerated drug discovery
Physicists at the University of Bath and University of Michigan demonstrate a new photonic effect in semiconducting nanohelices. A new photonic effect in semiconducting helical particles with nanoscale dimensions has been discovered by an international team of scientists led by researchers at the University of Bath.

Health - Pharmacology - 05.01.2022
New test can identify if a patient has cancer and if it has spread
New test can identify if a patient has cancer and if it has spread
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. A University of Oxford study published in Clinical Cancer Research , a journal of the American Association for Cancer Research, outlines a new type of blood test that can be used to detect a range of cancers and whether these cancers have spread (metastasised) in the body.

Health - Pharmacology - 04.01.2022
Superbug MRSA arose in hedgehogs long before clinical use of antibiotics
Superbug MRSA arose in hedgehogs long before clinical use of antibiotics
Scientists have found evidence that a type of the antibiotic resistant superbug MRSA arose in nature long before the use of antibiotics in humans and livestock, which has traditionally been blamed for its emergence.

Health - Pharmacology - 04.01.2022
Easy-to-take medicine better at suppressing HIV in children
Easy-to-take medicine better at suppressing HIV in children
A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments, according to a global trial led by researchers at UCL. The study, published today in The New England Journal of Medicine , found that dolutegravir-based regimens, which are already widely used to treat adults, reduced the chances of treatment failure among young people aged three to 18 by around 40% compared to standard treatments.

Health - Pharmacology - 03.01.2022
Scale of prevalence of a condition that can cause type 2 diabetes and high blood pressure
Share this page Share on Twitter Share on facebook Share on linkedin Share on email Scientists at the University of Birmingham are calling for changes to healthcare policy following research which has shown for the first time the scale of the impact of a condition associated with benign tumours that can lead to type 2 diabetes and high blood pressure.